T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Broadcom
AVGO
|
+$3.52B |
| 2 |
Boeing
BA
|
+$1.89B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.43B |
| 4 |
Amphenol
APH
|
+$1.1B |
| 5 |
CME Group
CME
|
+$911M |
Top Sells
| 1 |
Apple
AAPL
|
+$3.87B |
| 2 |
Advanced Micro Devices
AMD
|
+$2.1B |
| 3 |
UnitedHealth
UNH
|
+$1.83B |
| 4 |
Uber
UBER
|
+$1.56B |
| 5 |
Adobe
ADBE
|
+$1.29B |
Sector Composition
| 1 | Technology | 33.26% |
| 2 | Healthcare | 12.77% |
| 3 | Consumer Discretionary | 11.7% |
| 4 | Financials | 11.14% |
| 5 | Communication Services | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
576
Globus Medical
GMED
$7.89B
| $92.9M | 0.01% |
1,123,132
-9,901
| -0.9% | -$819K |
|
577
Xencor
XNCR
$596M
| $92.8M | 0.01% |
4,036,412
+107,350
| +3% | +$2.47M |
|
578
The Ensign Group
ENSG
$9.59B
| $92.5M | 0.01% |
696,061
-105,556
| -13% | -$14M |
|
579
Iron Mountain
IRM
$28.8B
| $92.2M | 0.01% |
877,238
+57,104
| +7% | +$6M |
|
580
Braze
BRZE
$3.35B
| $92M | 0.01% |
2,197,407
+1,203,149
| +121% | +$50.4M |
|
581
News Corp Class B
NWS
$17.8B
| $91.6M | 0.01% |
3,011,333
-270,830
| -8% | -$8.24M |
|
|
DFS
582
DELISTED
Discover Financial Services
DFS
| $91M | 0.01% |
525,386
-866,821
| -62% | -$150M |
|
583
Leidos
LDOS
$23.1B
| $90.5M | 0.01% |
628,463
-253,961
| -29% | -$36.6M |
|
584
Clorox
CLX
$15.1B
| $90.1M | 0.01% |
554,688
+163,341
| +42% | +$26.5M |
|
585
CoStar Group
CSGP
$36.6B
| $89.9M | 0.01% |
1,256,421
-14,910
| -1% | -$1.07M |
|
586
Celldex Therapeutics
CLDX
$1.66B
| $89.9M | 0.01% |
3,557,136
+676,771
| +23% | +$17.1M |
|
|
CNTA
587
Centessa Pharmaceuticals
CNTA
$3.04B
| $89.9M | 0.01% |
5,364,392
+685,371
| +15% | +$11.5M |
|
588
Delta Air Lines
DAL
$40.1B
| $89.7M | 0.01% |
1,482,161
-470,687
| -24% | -$28.5M |
|
589
Evercore
EVR
$12.8B
| $89.6M | 0.01% |
323,324
+300,032
| +1,288% | +$83.2M |
|
590
Coca-Cola Consolidated
COKE
$10.5B
| $89.4M | 0.01% |
709,780
-130
| -0% | -$16.4K |
|
591
Hologic
HOLX
$14.6B
| $88.7M | 0.01% |
1,229,855
-1,572,074
| -56% | -$113M |
|
592
Disc Medicine
IRON
$2.08B
| $88.4M | 0.01% |
1,394,637
+262,690
| +23% | +$16.7M |
|
593
Kanzhun
BZ
$11.2B
| $87.7M | 0.01% |
6,355,463
-6,471,901
| -50% | -$89.3M |
|
594
On Holding
ONON
$14B
| $87.7M | 0.01% |
1,600,649
+79,680
| +5% | +$4.36M |
|
595
Payoneer
PAYO
$2.33B
| $87.5M | 0.01% |
8,709,989
+440,231
| +5% | +$4.42M |
|
596
Onto Innovation
ONTO
$5.2B
| $87.3M | 0.01% |
523,674
-40,338
| -7% | -$6.72M |
|
597
T. Rowe Price Equity Income ETF
TEQI
$325M
| $86.6M | 0.01% |
2,134,101
+484,100
| +29% | +$19.6M |
|
598
LPL Financial
LPLA
$27.4B
| $86M | 0.01% |
263,268
-352,717
| -57% | -$115M |
|
599
Aflac
AFL
$57.3B
| $85.3M | 0.01% |
824,947
+23,455
| +3% | +$2.43M |
|
600
Baidu
BIDU
$37B
| $85.3M | 0.01% |
1,011,792
-2,120
| -0.2% | -$179K |
|